FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310383663> ?p ?o ?g. }

• W4310383663 abstract "Abaloparatide is a peptide analog of parathyroid hormone-related protein (PTHrP 1-34) and was approved in 2017 as the second osteoanabolic peptide for treating osteoporosis. We previously showed that intermittent abaloparatide is equally as effective as PTH (1-34). This study was designed to compare the catabolic effects of PTH (1-34) and abaloparatide on bone in young female wild-type mice. Two-month-old C57Bl/6J female mice were continuously infused with human PTH (1-34) or abaloparatide at 80 μg/kg BW/day or vehicle for 2 weeks. At euthanasia, DEXA-PIXImus was performed to assess bone mineral density (BMD) in the whole body, femurs, tibiae, and vertebrae. Bone turnover marker levels were measured in sera, femurs were harvested for micro-computer tomography (μCT) analyses and histomorphometry, and tibiae were separated into cortical and trabecular fractions for gene expression analyses. Our results demonstrated that the infusion of abaloparatide resulted in a similar decrease in BMD as infused PTH (1-34) at all sites. μCT and histomorphometry analyses showed similar decreases in cortical bone thickness and BMD associated with an increase in bone turnover from the increased bone formation rate found by in vivo double labeling and serum P1NP and increased bone resorption as shown by osteoclast numbers and serum cross-linked C-telopeptide. Trabecular bone did not show major changes with either treatment. Osteoblastic gene expression analyses of trabecular and cortical bone revealed that infusion of PTH (1-34) or abaloparatide led to similar and different actions in genes of osteoblast differentiation and activity. As with intermittent and in vitro treatment, both infused PTH (1-34) and abaloparatide similarly regulated downstream genes of the PTHR1/SIK/HDAC4 pathway such as Sost and Mmp13 but differed for those of the PTHR1/SIK/CRTC pathway. Taken together, at the same dose, infused abaloparatide causes the same high bone turnover as infused PTH (1-34) with a net resorption in female wild-type mice. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research." @default.
• W4310383663 created "2022-12-10" @default.
• W4310383663 creator A5046072048 @default.
• W4310383663 creator A5050779627 @default.
• W4310383663 creator A5059555779 @default.
• W4310383663 creator A5063918023 @default.
• W4310383663 creator A5068862725 @default.
• W4310383663 creator A5088476790 @default.
• W4310383663 date "2023-01-05" @default.
• W4310383663 modified "2023-10-10" @default.
• W4310383663 title "Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as <scp>PTH</scp> (1–34)" @default.
• W4310383663 cites W1854708535 @default.
• W4310383663 cites W1911703092 @default.
• W4310383663 cites W1967967197 @default.
• W4310383663 cites W1968149289 @default.
• W4310383663 cites W1971720206 @default.
• W4310383663 cites W1986713541 @default.
• W4310383663 cites W1989400609 @default.
• W4310383663 cites W1993798820 @default.
• W4310383663 cites W1997076062 @default.
• W4310383663 cites W2000647744 @default.
• W4310383663 cites W2016696096 @default.
• W4310383663 cites W2018613779 @default.
• W4310383663 cites W2030561743 @default.
• W4310383663 cites W2033737664 @default.
• W4310383663 cites W2036857341 @default.
• W4310383663 cites W2037447928 @default.
• W4310383663 cites W2041598849 @default.
• W4310383663 cites W2046862403 @default.
• W4310383663 cites W2053261087 @default.
• W4310383663 cites W2061769753 @default.
• W4310383663 cites W2062814325 @default.
• W4310383663 cites W2066749771 @default.
• W4310383663 cites W2067411979 @default.
• W4310383663 cites W2069860666 @default.
• W4310383663 cites W2075364766 @default.
• W4310383663 cites W2086805722 @default.
• W4310383663 cites W2087378917 @default.
• W4310383663 cites W2087692142 @default.
• W4310383663 cites W2092772070 @default.
• W4310383663 cites W2096425957 @default.
• W4310383663 cites W2099028287 @default.
• W4310383663 cites W2101487607 @default.
• W4310383663 cites W2104357139 @default.
• W4310383663 cites W2105860930 @default.
• W4310383663 cites W2139697060 @default.
• W4310383663 cites W2139785110 @default.
• W4310383663 cites W2158401140 @default.
• W4310383663 cites W2159816244 @default.
• W4310383663 cites W2167055214 @default.
• W4310383663 cites W2176994106 @default.
• W4310383663 cites W2221707331 @default.
• W4310383663 cites W2466803346 @default.
• W4310383663 cites W2509957583 @default.
• W4310383663 cites W2516614130 @default.
• W4310383663 cites W2538948868 @default.
• W4310383663 cites W2547154847 @default.
• W4310383663 cites W2553823910 @default.
• W4310383663 cites W2561669056 @default.
• W4310383663 cites W2569948192 @default.
• W4310383663 cites W2599538813 @default.
• W4310383663 cites W2617272137 @default.
• W4310383663 cites W2739066978 @default.
• W4310383663 cites W2767646448 @default.
• W4310383663 cites W2770400775 @default.
• W4310383663 cites W2775903390 @default.
• W4310383663 cites W2791421543 @default.
• W4310383663 cites W2803459905 @default.
• W4310383663 cites W2896539080 @default.
• W4310383663 cites W2898979213 @default.
• W4310383663 cites W2938352109 @default.
• W4310383663 cites W2977851725 @default.
• W4310383663 cites W2991137093 @default.
• W4310383663 cites W3038107200 @default.
• W4310383663 cites W3129582999 @default.
• W4310383663 cites W3156333668 @default.
• W4310383663 cites W3191990699 @default.
• W4310383663 cites W3193174831 @default.
• W4310383663 cites W4211249087 @default.
• W4310383663 doi "https://doi.org/10.1002/jbm4.10710" @default.
• W4310383663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36751417" @default.
• W4310383663 hasPublicationYear "2023" @default.
• W4310383663 type Work @default.
• W4310383663 citedByCount "0" @default.
• W4310383663 crossrefType "journal-article" @default.
• W4310383663 hasAuthorship W4310383663A5046072048 @default.
• W4310383663 hasAuthorship W4310383663A5050779627 @default.
• W4310383663 hasAuthorship W4310383663A5059555779 @default.
• W4310383663 hasAuthorship W4310383663A5063918023 @default.
• W4310383663 hasAuthorship W4310383663A5068862725 @default.
• W4310383663 hasAuthorship W4310383663A5088476790 @default.
• W4310383663 hasBestOaLocation W43103836631 @default.
• W4310383663 hasConcept C105702510 @default.
• W4310383663 hasConcept C126322002 @default.
• W4310383663 hasConcept C134018914 @default.
• W4310383663 hasConcept C146562846 @default.
• W4310383663 hasConcept C170033053 @default.
• W4310383663 hasConcept C170493617 @default.
• W4310383663 hasConcept C185592680 @default.
• W4310383663 hasConcept C202751555 @default.

• next